Insulin Delivery Technology for Treatment of Infants with Neonatal Diabetes Mellitus: A Systematic Review.
Advanced hybrid closed loop
Diabetes technology
Hybrid closed loop
Insulin infusion systems
Insulin pump
Neonatal diabetes mellitus
Journal
Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025
Informations de publication
Date de publication:
18 Sep 2024
18 Sep 2024
Historique:
received:
01
08
2024
accepted:
06
09
2024
medline:
18
9
2024
pubmed:
18
9
2024
entrez:
18
9
2024
Statut:
aheadofprint
Résumé
Neonatal diabetes mellitus is a rare disorder of glucose metabolism with onset within the first 6 months of life. The initial treatment is based on insulin infusion. The technologies for diabetes treatment can be very helpful, even if guidelines are still lacking. The current study aimed to provide a comprehensive review of the literature about the safety and efficacy of insulin treatment with technology for diabetes to support clinicians in the management of infants with neonatal diabetes mellitus. A total of 22 papers were included, most of them case reports or case series. The first infants with neonatal diabetes mellitus treated with insulin pumps were described nearly two decades ago. Over the years, continuous glucose monitoring systems were added to treat these individuals, allowing for a better customization of insulin administration. Insulin was diluted in some cases to further minimize the doses. Improvement in technology for diabetes prompted clinicians to use new devices and algorithms for insulin delivery in infants with neonatal diabetes as well. These systems are safe and effective, may shorten hospital stay, and help clinicians weaning insulin during the remission phase in the transient forms or switching from insulin to sulfonylurea when suggested by the molecular diagnosis. New technologies for insulin delivery in infants with neonatal diabetes can be used safely and closed-loop algorithms can work properly in these situations, optimizing blood glucose control.
Identifiants
pubmed: 39292435
doi: 10.1007/s13300-024-01653-z
pii: 10.1007/s13300-024-01653-z
doi:
Types de publication
Journal Article
Review
Langues
eng
Informations de copyright
© 2024. The Author(s).
Références
Greeley SAW, Polak M, Njølstad PR, Barbetti F, Williams R, Castano L, Raile K, Chi DV, Habeb A, Hattersley AT, Codner E. ISPAD Clinical Practice Consensus Guidelines 2022: the diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1188–211.
doi: 10.1111/pedi.13426
pubmed: 36537518
pmcid: 10107883
Habeb AM, Flanagan SE, Deeb A, et al. Permanent neonatal diabetes: different etiology in Arabs compared to Europeans. Arch Dis Child. 2012;97:721–3. https://doi.org/10.1136/archdischild-2012-301744 .
doi: 10.1136/archdischild-2012-301744
pubmed: 22859427
Al-Khawaga S, Mohammed I, Saraswathi S, Haris B, Hasnah R, Saeed A, Almabrazi H, Syed N, Jithesh P, El Awwa A, Khalifa A, AlKhalaf F, Petrovski G, Abdelalim EM, Hussain K. The clinical and genetic characteristics of permanent neonatal diabetes (PNDM) in the state of Qatar. Mol Genet Genomic Med. 2019;7(10): e00753. https://doi.org/10.1002/mgg3.753 .
doi: 10.1002/mgg3.753
pubmed: 31441606
pmcid: 6785445
Iafusco D, Massa O, Pasquino B, et al. Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol. 2012;49:405–8. https://doi.org/10.1007/s00592-011-0331-8 .
doi: 10.1007/s00592-011-0331-8
pubmed: 21953423
Delvecchio M, Ortolani F, Rutigliano A, Vendemiale M, Piccinno E. Epidemiology. In: Neonatal and early onset diabetes mellitus. Cham: Springer; 2023. p. 23–38.
doi: 10.1007/978-3-031-07008-2_3
Barbetti F, Mammì C, Liu M, Grasso V, Arvan P, Remedi M, Nichols C. Neonatal diabetes: permanent neonatal diabetes and transient neonatal diabetes. In: Barbetti F, Ghizzoni L, Guaraldi F, editors. Frontiers in diabetes diabetes associated with single gene defects and chromosomal abnormalities. Karger Publishers AG; 2017. p. 1–25.
doi: 10.1159/isbn.978-3-318-06025-6
Busiah K, Drunat S, Vaivre-Douret L, et al. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]. Lancet Diabetes Endocrinol. 2013;1(3):199–207. https://doi.org/10.1016/S2213-8587(13)70059-7 .
doi: 10.1016/S2213-8587(13)70059-7
pubmed: 24622368
Bowman P, Sulen Å, Barbetti F, Beltrand J, Svalastoga P, Codner E, Tessmann EH, Juliusson PB, Skrivarhaug T, Pearson ER, Flanagan SE, Babiker T, Thomas NJ, Shepherd MH, Ellard S, Klimes I, Szopa M, Polak M, Iafusco D, Hattersley AT, Njølstad PR, Neonatal Diabetes International Collaborative Group. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. Lancet Diabetes Endocrinol. 2018;6(8):637–46. https://doi.org/10.1016/S2213-8587(18)30106-2 .
doi: 10.1016/S2213-8587(18)30106-2
pubmed: 29880308
pmcid: 6058077
Bowman P, Mathews F, Barbetti F, Shepherd MH, Sanchez J, Piccini B, Beltrand J, Letourneau-Freiberg LR, Polak M, Greeley SAW, Rawlins E, Babiker T, Thomas NJ, De Franco E, Ellard S, Flanagan SE, Hattersley AT, Neonatal Diabetes International Collaborative Group. Long-term follow-up of glycemic and neurological outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 permanent neonatal diabetes. Diabetes Care. 2021;44(1):35–42. https://doi.org/10.2337/dc20-1520 .
doi: 10.2337/dc20-1520
pubmed: 33184150
Rabbone I, Barbetti F, Gentilella R, et al. Insulin therapy in neonatal diabetes mellitus: a review of the literature. Diabetes Res Clin Pract. 2017;129:126–35.
doi: 10.1016/j.diabres.2017.04.007
pubmed: 28527303
Kapellen TM, Heidtmann B, Lilienthal E, et al. Continuous subcutaneous insulin infusion in neonates and infants below 1 year: analysis of initial bolus and basal rate based on the experiences from the German Working Group for Pediatric Pump Treatment. Diabetes Technol Ther. 2015;17:872–9.
doi: 10.1089/dia.2015.0030
pubmed: 26509360
Sherr JL, Schoelwer M, Dos Santos TJ, Reddy L, Biester T, Galderisi A, van Dyk JC, Hilliard ME, Berget C, DiMeglio LA. ISPAD Clinical Practice Consensus Guidelines 2022: diabetes technologies: insulin delivery. Pediatr Diabetes. 2022;23(8):1406–31. https://doi.org/10.1111/pedi.13421 .
doi: 10.1111/pedi.13421
pubmed: 36468192
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339: b2700. https://doi.org/10.1136/bmj.b2700 .
doi: 10.1136/bmj.b2700
pubmed: 19622552
pmcid: 2714672
Delvecchio M, Panza R, Schettini F, Piccinno E, Laforgia N. Safety and effectiveness of Medtronic MiniMed
doi: 10.1007/s00592-023-02212-x
pubmed: 38197960
Olinder AL, Kernell A, Smide B. Treatment with CSII in two infants with neonatal diabetes mellitus. Pediatr Diabetes. 2006;7:284–8.
doi: 10.1111/j.1399-5448.2006.00203.x
pubmed: 17054451
Park JH, Kang JH, Lee KH, Kim NH, Yoo HW, Lee DY, Yoo EG. Insulin pump therapy in transient neonatal diabetes mellitus. Ann Pediatr Endocrinol Metab. 2013;18:148–51.
doi: 10.6065/apem.2013.18.3.148
pubmed: 24904869
pmcid: 4027075
Tubiana-Rufi N. Insulin pump therapy in neonatal diabetes. Endocr Dev. 2007;12:67–74.
doi: 10.1159/000109606
pubmed: 17923770
Ortolani F, Piccinno E, Grasso V, Papadia F, Panzeca R, Cortese C, Felappi B, Tummolo A, Vendemiale M, Barbetti F. Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment. Acta Diabetol. 2016;53:499.
doi: 10.1007/s00592-015-0793-1
pubmed: 26239141
Marin MT, Coffey ML, Beck JK, Dasari PS, Allen R, Krishnan S. A novel approach to the management of neonatal diabetes using sensor-augmented insulin pump therapy with threshold suspend technology at diagnosis. Diabetes Spectr. 2016;29:176–9.
doi: 10.2337/diaspect.29.3.176
pubmed: 27574373
pmcid: 5001214
Fudvoye J, Farhat K, De Halleux V, Nicolescu CR. 6q24 transient neonatal diabetes—how to manage while waiting for genetic results. Front Pediatr. 2016;17(4):124. https://doi.org/10.3389/fped.2016.00124 .
doi: 10.3389/fped.2016.00124
Alyafie F, Soliman AT, Sabt A, Elawwa A, Alkhalaf F, Alzyoud M, De Sanctis V. Postnatal growth of Infants with neonatal diabetes: insulin pump (CSII) versus Multiple Daily Injection (MDI) therapy. Acta Biomed. 2019;90:28–35.
pubmed: 31544804
pmcid: 7233682
Torbjörnsdotter T, Marosvari-Barna E, Henckel E, Corrias M, Norgren S, Janson A. Successful treatment of a cohort of infants with neonatal diabetes using insulin pumps including data on genetics and estimated incidence. Acta Paediatr. 2020;109:1131–7.
doi: 10.1111/apa.15100
pubmed: 31746017
Zanfardino A, Piscopo A, Curto S, Schiaffini R, Rollato AS, Testa V, Miraglia Del Giudice E, Barbetti F, Iafusco D. Very low birth weight newborn with diabetes mellitus due to pancreas agenesis managed with insulin pump reservoir filled with undiluted insulin: 16-month follow-up. Diabetes Metab Syndr. 2022;16: 102561.
doi: 10.1016/j.dsx.2022.102561
pubmed: 35809554
Zanfardino A, Carpentieri M, Piscopo A, Curto S, Miraglia Del Giudice E, Inverardi A, Diplomatico M, Moschella S, Spagnuolo F, Caredda E, Montaldo P, Iafusco D. Sensor augmented pump therapy is safe and effective in very low birth weight newborns affected by neonatal diabetes mellitus, with poor subcutaneous tissue: replacement of the insulin pump infusion set on the arm, a video case report. J Diabetes Sci Technol. 2022;16:254–5.
doi: 10.1177/19322968211043112
pubmed: 34474595
Passanisi S, Timpanaro T, Lo Presti D, Mammì C, Caruso-Nicoletti M. Treatment of transient neonatal diabetes mellitus: insulin pump or insulin glargine? Our experience. Diabetes Technol Ther. 2014;16:880–4.
doi: 10.1089/dia.2014.0055
pubmed: 25437016
pmcid: 4241878
Kurnaz E, Aycan Z, Yıldırım N, et al. Conventional insulin pump therapy in two neonatal diabetes patients harboring the homozygous PTF1A enhancer mutation: Need for a novel approach for the management of neonatal diabetes. Turk J Pediatr. 2017;59:458–62. https://doi.org/10.24953/turkjped.2017.04.013 .
doi: 10.24953/turkjped.2017.04.013
pubmed: 29624227
London S, De Franco E, Elias-Assad G, Barhoum MN, Felszer C, Paniakov M, Weiner SA, Tenenbaum-Rakover Y. Case report: neonatal diabetes mellitus caused by a Novel GLIS3 mutation in twins. Front Endocrinol (Lausanne). 2021. https://doi.org/10.3389/fendo.2021.673755 .
doi: 10.3389/fendo.2021.673755
pubmed: 34093443
Huggard D, Stack T, Satas S, Gorman CO. Donohue syndrome and use of continuous subcutaneous insulin pump therapy. BMJ Case Rep. 2015;2015:5–8.
Rabbone I, Barbetti F, Marigliano M, Bonfanti R, Piccinno E, Ortolani F, Ignaccolo G, Maffeis C, Confetto S, Cerutti F, Zanfardino A, Iafusco D. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis. Acta Diabetol. 2016;53:559–65. https://doi.org/10.1007/s00592-015-0828-7 .
doi: 10.1007/s00592-015-0828-7
pubmed: 26831749
Fukuda Y, Ishii A, Kamasaki H, Fusagawa S, Terada K, Igarashi L, Kobayashi M, Suzuki S, Tsugawa T. Long-term sensor-augmented pump therapy for neonatal diabetes mellitus: a case series. Clin Pediatr Endocrinol. 2022;31:178–84.
doi: 10.1297/cpe.2022-0005
pubmed: 35928380
pmcid: 9297173
Sakai R, Kikuchi N, Nishi D, Horiguchi H. Successful termination of insulin therapy in transient neonatal diabetes mellitus. Case Rep Pediatr. 2023;2023(11):6667330.
pubmed: 38116130
pmcid: 10728360
Lee MY, Gloyn AL, Maahs DM, Prahalad P. Management of neonatal diabetes due to a KCNJ11 mutation with automated insulin delivery system and remote patient monitoring. Case Rep Endocrinol. 2023;2023:8825724.
pubmed: 37664823
pmcid: 10468271
Mancioppi V, Pozzi E, Zanetta S, Missineo A, Savastio S, Barbetti F, Mellone S, Giordano M, Rabbone I. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants. Front Endocrinol (Lausanne). 2023. https://doi.org/10.3389/fendo.2023.1143736 .
doi: 10.3389/fendo.2023.1143736
pubmed: 37501786
Wanaguru A, Phan P, Lim L, Verge C, Hameed S, Neville K. Advanced hybrid closed-loop use in children less than 2 years old with diluted insulin: a case series. Acta Diabetol. 2024;61(2):257–61. https://doi.org/10.1007/s00592-023-02218-5 .
doi: 10.1007/s00592-023-02218-5
pubmed: 38097818
Rapini N, Delvecchio M, Mucciolo M, et al. The changing landscape of neonatal diabetes mellitus in Italy between 2003–2022. J Clin Endocrinol Metab. 2024;109(9):2349–57. https://doi.org/10.1210/clinem/dgae095 .
doi: 10.1210/clinem/dgae095
pubmed: 38408297
pmcid: 11319002
Besser RE, Flanagan SE, Mackay DG, et al. Prematurity and genetic testing for neonatal diabetes. Pediatrics. 2016;138(3): e20153926. https://doi.org/10.1542/peds.2015-3926 .
doi: 10.1542/peds.2015-3926
pubmed: 27540106
Klingensmith GJ. Use of insulin pump in neonates and toddlers. Diabetes Technol Ther. 2015;17(12):857–9. https://doi.org/10.1089/dia.2015.0339 .
doi: 10.1089/dia.2015.0339
pubmed: 26618720
Habeb AM, Deeb A, Elbarbary N, Beshyah SA. Diagnosis and management of neonatal diabetes mellitus: a survey of physicians’ perceptions and practices in ASPED countries. Diabetes Res Clin Pract. 2020;159: 107975. https://doi.org/10.1016/j.diabres.2019.107975 .
doi: 10.1016/j.diabres.2019.107975
pubmed: 31830516
Chisnoiu T, Balasa AL, Mihai L, et al. Continuous glucose monitoring in transient neonatal diabetes mellitus-2 case reports and literature review. Diagnostics (Basel). 2023;13(13):2271. https://doi.org/10.3390/diagnostics13132271 .
doi: 10.3390/diagnostics13132271
pubmed: 37443665
McKinlay CJD, Chase JG, Dickson J, Harris DL, Alsweiler JM, Harding JE. Continuous glucose monitoring in neonates: a review. Matern Health Neonatol Perinatol. 2017;3:18. https://doi.org/10.1186/s40748-017-0055-z .
doi: 10.1186/s40748-017-0055-z
pubmed: 29051825
pmcid: 5644070